The oral commensal Streptococcus mitis shows a mixed memory Th cell signature that is similar to and cross-reactive with Streptococcus pneumoniae

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Engen, Stian André ^a   Rukke, Håkon Valen ^a   Becattini, Simone ^b   Jarrossay, David ^b   Blix, Inger Johanne ^a   Petersen, Fernanda Cristina ^a   Sallusto, Federica ^b   Schenck, Karl ^a  

^a UNIVERSITY OF OSLO   (Norway)

^b INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22;

CROSS REACTION; HELPER CELL; HUMAN; IMMUNOLOGY; MICROBIOLOGY; MOUTH; STREPTOCOCCUS MITIS; STREPTOCOCCUS PNEUMONIAE;

CROSS REACTIONS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKINS; MOUTH; STREPTOCOCCUS MITIS; STREPTOCOCCUS PNEUMONIAE; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 84905992284     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104306     Document Type: Article

References (38)

1. Aas JA, Paster BJ, Stokes LN, Olsen I, Dewhirst FE (2005) Defining the normal bacterial flora of the oral cavity. J Clin Microbiol 43: 5721-32. (Pubitemid 41612354)
2. Dewhirst FE, Chen T, Izard J, Paster BJ, Tanner AC, et al. (2010) The human oral microbiome. J Bacteriol 192: 5002-17.
3. Zaura E, Keijser BJ, Huse SM, Crielaard W (2009) Defining the healthy "core microbiome" of oral microbial communities. BMC Microbiol 9: 259.
4. Brandtzaeg P (2001) Inflammatory bowel disease: clinics and pathology. Do inflammatory bowel disease and periodontal disease have similar immunopathogeneses? Acta Odontol Scand 59: 235-43.
5. Donati C, Hiller NL, Tettelin H, Muzzi A, Croucher NJ, et al. (2010) Structure and dynamics of the pan-genome of Streptococcus pneumoniae and closely related species. Genome Biol 11: R107.
6. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, et al. (2009) Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 374: 893-902.
7. Granat SM, Ollgren J, Herva E, Mia Z, Auranen K, et al. (2009) Epidemiological evidence for serotype-independent acquired immunity to pneumococcal carriage. J Infect Dis. 200: 99-106.
8. Rapola S, Jäntti V, Haikala R, Syrjänen R, Carlone GM, et al. (2000) Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesion A, and pneumolysin in relation to pneumococcal carriage and acute otitis media. J Infect Dis. 182: 1146-52.
9. Lipsitch M, Whitney CG, Zell E, Kaijalainen T, Dagan R, et al. (2005) Are anticapsular antibodies the primary mechanism of protection against invasive pneumococcal disease? PLoS Med. 2: e15.
10. Lundgren A, Bhuiyan TR, Novak D, Kaim J, Reske A, et al. (2012) Characterization of Th17 responses to Streptococcus pneumoniae in humans: Comparisons between adults and children in a developed and a developing country. Vaccine 6; 30: 3897-907.
11. Wirth KA, Bowden GH, Kirchherr JL, Richmond DA, Sheridan MJ, et al. (2008) Humoral immunity to commensal oral bacteria in human infants: evidence that Streptococcus mitis biovar 1 colonization induces strain-specific salivary immunoglobulin A antibodies. ISME J 2: 728-38. (Pubitemid 351951562)
12. Kirchherr JL, Bowden GH, Richmond DA, Sheridan MJ, Wirth KA, et al. (2005) Clonal diversity and turnover of Streptococcus mitis bv. 1 on shedding and nonshedding oral surfaces of human infants during the first year of life. Clin Diagn Lab Immunol 12: 1184-90. (Pubitemid 41475826)
13. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348-57. (Pubitemid 16136806)
14. Langrish CL, Chen Y, Blumenschein WM, Mattson J, Basham B, et al. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 201: 233-40. (Pubitemid 40189432)
15. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F (2009) Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 10: 857-63.
16. Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H (2009) Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 10: 864-71.
17. Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, et al. (2008) Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 9: 1341-6.
18. Acosta-Rodriguez EV, Rivino L, Geginat J, Jarrossay D, Gattorno M, et al. (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8: 639-46. (Pubitemid 46785128)
19. Cosmi L, De Palma R, Santarlasci V, Maggi L, Capone M, et al. (2008) Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J Exp Med 205: 1903-16.
20. Cosmi L, Maggi L, Santarlasci V, Capone M, Cardilicchia E, et al. (2010) Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol 125: 222-30.
21. Rukke HV, Hegna IK, Petersen FC (2012) Identification of a functional capsule locus in Streptococcus mitis. Mol Oral Microbiol 27: 95-108.
22. Geiger R, Duhen T, Lanzavecchia A, Sallusto F (2009) Human naive and memory CD4+ T cell repertoires specific for naturally processed antigens analyzed using libraries of amplified T cells. J Exp Med 206: 1525-34.
23. Lefkovits I, Waldmann H (1999) Limiting dilution analysis of cells of the immune system. Oxford: Oxford University Press. 285 p.
24. Kalka-Moll WM, Tzianabos AO, Bryant PW, Niemeyer M, Ploegh HL, et al. (2002) Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions. J Immunol 169: 6149-53. (Pubitemid 36903459)
25. Belkaid Y, Bouladoux N, Hand TW (2013) Effector and memory T cell responses to commensal bacteria. Trends Immunol 34: 299-306.
26. Zielinski CE, Corti D, Mele F, Pinto D, Lanzavecchia A, et al. (2011) Dissecting the human immunologic memory for pathogens. Immunol Rev 240: 40-51.
27. Pido-Lopez J, Kwok WW, Mitchell TJ, Heyderman RS, Williams NA (2011) Acquisition of pneumococci specific effector and regulatory Cd4+ T cells localising within human upper respiratory-tract mucosal lymphoid tissue. PLoS Pathog 7: e1002396.
28. Wright AK, Bangert M, Gritzfeld JF, Ferreira DM, Jambo KC, et al. (2013) Experimental human pneumococcal carriage augments IL-17A-dependent T-cell defence of the lung. PLoS Pathog 9: e1003274.
29. Nistala K, Adams S, Cambrook H, Ursu S, Olivito B, et al. (2010) Th17 plasticity in human autoimmune arthritis is driven by the inflammatory environment. Proc Natl Acad Sci U S A 107: 14751-6.
30. Ramesh R, Kozhaya L, McKevitt K, Djuretic IM, Carlson TJ, et al. (2014) Proinflammatory human Th17 cells selectively express P-glycoprotein and are refractory to glucocorticoids. J Exp Med 211: 89-104.
31. Glennie SJ, Banda D, Gould K, Hinds J, Kamngona A, et al. (2013) Defective pneumococcal-specific Th1 responses in HIV-infected adults precedes a loss of control of pneumococcal colonization. Clin Infect Dis 56: 291-9.
32. Paats MS, Bergen IM, Hanselaar WE, van Zoelen EC, Verbrugh HA, et al. (2013) T helper 17 cells are involved in the local and systemic inflammatory response in community-acquired pneumonia. Thorax 68: 468-74.
33. Rutz S, Eidenschenk C, Ouyang W (2013) IL-22, not simply a Th17 cytokine. Immunol Rev 252: 116-32.
34. Ivanov S, Renneson J, Fontaine J, Barthelemy A, Paget C, et al. (2013) Interleukin-22 reduces lung inflammation during influenza A virus infection and protects against secondary bacterial infection. J Virol 87: 6911-24.
35. Pletz MW, Maus U, Krug N, Welte T, Lode H (2008) Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species. Int J Antimicrob Agents 32: 199-206.
36. Velez CD, Lewis CJ, Kasper DL, Cobb BA (2009) Type I Streptococcus pneumoniae carbohydrate utilizes a nitric oxide and MHC II-dependent pathway for antigen presentation. Immunology 127: 73-82.
37. Moffitt KL, Malley R, Lu YJ (2012) Identification of protective pneumococcal T(H)17 antigens from the soluble fraction of a killed whole cell vaccine. PLoS One 7: e43445.
38. Welsh RM, Che JW, Brehm MA, Selin LK (2010) Heterologous immunity between viruses. Immunol Rev 235: 244-66.